CTLA4 and hypophysitis: Two patients presented with headache accompanied by changes consistent with hypophysitis on imaging and multiple pituitary hormone deficiencies both of which received combination anti-PD-1 and CTLA4 inhibitor therapy (nivolumab plus ipilimumab).